Azurette
Product Images NDC 53002-1601

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Azurette (NDC 53002-1601). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

Chemical structures of the active ingredients desogestrel and ethinyl estradiol are shown. Each structure includes the molecular formula below: C22H30O for desogestrel and C20H24O2 for ethinyl estradiol.*

FDA Label Image

Image-02 (Image 02)

A warning text panel about cigarette smoking risks associated with oral contraceptive use. It highlights increased cardiovascular side effects, especially in women over 35 and heavy smokers, advising women using oral contraceptives to avoid smoking.*

FDA Label Image

Image-03 (Image 03)

A bar chart illustrating circulatory disease mortality rates per 100,000 woman-years by age group (15–24, 25–34, 35–44, 45+) and by smoking status and oral contraceptive use. The chart compares ever-users and controls who are smokers and non-smokers, showing mortality rates increasing with age and higher rates among smokers, especially ever-users.*

FDA Label Image

Image-04 (Image 04)

Text warning that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. The risk increases with age and heavy smoking (15 or more cigarettes per day), especially in women over 35 years. Women using oral contraceptives are strongly advised not to smoke.*

FDA Label Image

Image-05 (Image 05)

Azurette tablet blister carton panel showing dose timing and day-of-week tracking. The blister contains dark blue, white, and green tablets arranged by day Monday through Sunday, with dosing instructions for a 28-tablet oral contraceptive pack labeled by RPK Pharmaceuticals, Inc.*

FDA Label Image

Image-06 (Image 06)

An instructional diagram showing how to apply a day label on a strip of Azurette tablets. The image illustrates a hand peeling a strip labeled with days of the week (MON through SUN) to place it on the blister pack to help track daily tablet use.*

FDA Label Image

Image-07 (Image 07)

Warning text panel stating that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use, with higher risk for women over 35 years and heavy smokers (15 or more cigarettes per day). It strongly advises women using oral contraceptives not to smoke.*

FDA Label Image

Image-08 (Image 08)

An illustrated calendar-style weekly pill reminder chart showing days Sunday through Saturday vertically with colored circles representing tablet days: dark blue for weeks one, two, and three, and white/green for week four. Instructions include taking the dark blue tablets first, storing them in a blister pack, and keeping tablets at controlled room temperature away from heat, moisture, and direct light.*

FDA Label Image

Image-09 (Image 09)

An instructional illustration showing how to apply a day label to a weekly pill blister pack labeled Azurette. The image directs to pick the correct day label from a strip of weekday labels and place it on the blister pack. The pack depicts rows of dark blue, white, and green tablets with labeled days. A hand is shown peeling the label strip for placement.*

FDA Label Image

Image-11 (Image 11)

FDA Label Image

Label Image (Lbl530021601)

Packaging label for Azurette tablets 28-day regimen by RPK Pharmaceuticals, Inc. The label indicates a 1-month pack containing 28 tablets with the direction to take 1 tablet daily. It includes areas for patient name and clinic information, billing codes, manufacturing, and expiration details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.